Related Experiment Videos
Clinical and functional differences among patients with idiopathic anaphylaxis
M A Tejedor Alonso1, J Sastre Dominguez, J J Sánchez-Hernández
1Sección de Alergia, Hospital General de Albacete. Spain. nurimang@idecnet.com
Journal of Investigational Allergology & Clinical Immunology
|November 24, 2004
Summary
Idiopathic anaphylaxis (IA) patients may be heterogeneous, with generalized IA linked to atopy and IA with angioedema linked to urticaria. Enhanced mast cell releaseability may contribute to these distinct presentations.
Area of Science:
- Immunology
- Allergy
- Dermatology
Background:
- Idiopathic anaphylaxis (IA) is poorly understood, with no prior studies assessing patient heterogeneity.
- Investigating potential subtypes of IA is crucial for understanding disease mechanisms.
Purpose of the Study:
- To determine if clinical and functional differences exist between Generalized Idiopathic Anaphylaxis (IA-G) and Idiopathic Anaphylaxis with Angioedema (IA-A).
- To assess mast cell releasability as a distinguishing factor between IA subtypes and other conditions.
Main Methods:
- A logistic regression model was used to analyze differences between 81 IA patients (IA-G and IA-A) from 1990-1995.
- Mast cell releasability was evaluated by analyzing cutaneous response to codeine in IA subtypes, atopic patients, urticaria patients, and healthy subjects.
- Statistical analyses included logistic regression, parallel line assay, and Hotelling's T2 test.
Main Results:
- Total IgE levels favored the presence of IA-G (O.R. 1.006).
- IA-G and IA-A patients exhibited higher cutaneous reactivity to codeine than atopic patients.
- IA-G patients showed lower codeine reactivity than urticaria patients, while IA-A patients did not differ significantly from urticaria patients.
Conclusions:
- Generalized Idiopathic Anaphylaxis (IA-G) appears associated with atopy.
- Idiopathic Anaphylaxis with Angioedema (IA-A) is linked to urticaria.
- Enhanced mast cell releasability may play a role in IA, particularly in atopic individuals.